Treating trauma in psychosis

Conditions

Psychosis and post-traumatic stress disorder/ psychiatry and psychology Mental and Behavioural Disorders Post-traumatic stress disorder

van den Berg DPG, van der Vleugel BM, de Bont PAJM, Staring ABP, Kraan T, Ising H, de Roos C, de Jongh A, van Minnen A, van der Gaag M.

2016-07-2110 citations

10.1016/j.schres.2016.07.016

Prolonged Exposure vs Eye Movement Desensitization and Reprocessing vs Waiting List for Posttraumatic Stress Disorder in Patients With a Psychotic Disorder

David Van Den Berg, Paul A. J. M. de Bont, Berber M. van der Vleugel, Carlijn de Roos, Ad de Jongh et al. (7 authors)

JAMA Psychiatry2015-01-21323 citations

10.1001/jamapsychiatry.2014.2637

A multi-site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: study protocol for the randomized controlled trial Treating Trauma in Psychosis.

de Bont PA, van den Berg DP, van der Vleugel BM, de Roos C, Mulder CL, Becker ES, de Jongh A, van der Gaag M, van Minnen A.

2013-05-2331 citations

10.1186/1745-6215-14-151

Interventions

In all three arms treatment as usual will be provided for the psychotic disorder for which the person sought help. In the experimental arms there will be a maximum of 8 sessions (over two months) of e

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Lifetime psychotic disorder as assessed by MINI 2. PTSD as assessed by CAPS 3. Outpatient 4. Age 18 to 65 years

Exclusion criteria

Exclusion criteria: 1. IQ under 70 2. No competence of the Dutch language 3. Not willing or able to travel to treatment location

Design outcomes

Primary

Measure	Time frame
1. Clinician Administered PTSD Scale (CAPS) diagnosis and severity 2. PTSD Symptom Scale Self-Report (PSS-SR) severity	—

Secondary

Measure	Time frame
1. Influence on psychosis (PANSS 8-item Remission Tool, GPTS and DRS in case of delusions, AHRS and AVH-BAS in case of auditory hallucinations) 2. Depression (BDI-II) 3. Social functioning (PSP) 4. Adverse events (TTIP Adverse Events Questionnaire) 5. Quality of life and cost-effectiveness (EQ5D, TIC-P)	—

Countries

Netherlands

Outcome results

None listed